As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of as-needed Budesonide/formoterol Turbuhaler 160/4.5
µg/d in the period of step down in well controlled asthmatic patient comparing with standard
maintenance therapy in step-2 management in asthma guildeline which is low dose inhaled
corticosteroid.
Phase:
Phase 3
Details
Lead Sponsor:
Hat Yai Medical Education Center
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate